Excel in a complex, competitive market with trusted market intelligence products and reports. Our carefully researched products give you the data needed to thoroughly assess key markets and segments and to identify opportunities for future growth.
Read MoreYour most challenging business questions require a customized solution. DeciBio Consulting provides tailored life science consulting services from industry veterans who have relevant clinical, research, and industry work experience. Partner with our seasoned experts to discover new market opportunities, evaluate how your products fit with customer needs, assess the impact of company initiatives, and understand market events and how they affect your company's bottom line and future growth.
Read More
100% of our cases focus on clinical diagnostics, research tools and health technology markets
70% of our consulting projects involve a global research perspective
More than 50% of our team has an advanced degree in a life science field
25% of our projects are supported by insights generated by big data analytics
Nobody has the combination of technical expertise, market insight, and strategic guidance that DeciBio possesses. Their work is thorough and data-driven, and they understand how their findings have a practical application to my business unit.
As our company defines its expansion and detailed business planning, DeciBio has helped us understand the strength of the company brand with top global pharmaceutical companies. DeciBio is an exceptional partner to organizations interested in optimizing their position in the biotechnology and clinical research market space.
DeciBio is simply the top life science market research / consultancy in the industry based on their depth of expertise, their laser focus on our industry, and their commitment to top-notch client service.
A Genomics-Based Approach to Radically Transform Healthcare I had the pleasure or speaking with Dr. Ashley Van Zeeland, co-founder and CEO of Cypher Genomics and current CTO of HLI (Human Longevity,…
Six years after the approval of the first checkpoint inhibitor, the explosion of research and development of cancer immunotherapies continues to accelerate at an unprecedented pace. As a class, cancer immunotherapies have…
Without a new and disruptive technology on the horizon, the proteomics market growth has stalled. In contrast, the genomics market has evolved rapidly over the past 10 years due to the arrival…
